MOLECULAR LINKS BETWEEN ALZHEIMER'S DISEASE AND DIABETES MELLITUS

被引:163
作者
Yang, Y. [1 ]
Song, W. [1 ]
机构
[1] Univ British Columbia, Grad Program Neurosci, Brain Res Ctr, Townsend Family Labs,Dept Psychiat, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
Alzheimer's disease; diabetes; molecular links; ISLET AMYLOID POLYPEPTIDE; INSULIN-DEGRADING ENZYME; GLYCATION END-PRODUCTS; CYTOCHROME-C-OXIDASE; TRANSGENIC MOUSE MODEL; HIPPOCAMPAL SYNAPTIC PLASTICITY; RANDOMIZED CONTROLLED-TRIAL; GROWTH-FACTOR EXPRESSION; FREE-RADICAL GENERATION; A-BETA ACCUMULATION;
D O I
10.1016/j.neuroscience.2013.07.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Substantial epidemiological evidence shows an increased risk for developing Alzheimer's disease (AD) in people with diabetes. Yet the underlying molecular mechanisms still remain to be elucidated. This article reviews the current studies on common pathological processes of Alzheimer's disease and diabetes with particular focus on potential mechanisms through which diabetes affects the initiation and progression of Alzheimer's disease. Impairment of insulin signaling, inflammation, oxidative stress, mitochondrial dysfunction, advanced glycation end products, APOE epsilon 4 and cholesterol appear to be important mediators and are likely to act synergistically in promoting AD pathology. (c) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:140 / 150
页数:11
相关论文
共 213 条
[1]   INSULIN AND INSULIN-LIKE GROWTH-FACTOR RECEPTORS IN THE NERVOUS-SYSTEM [J].
ADAMO, M ;
RAIZADA, MK ;
LEROITH, D .
MOLECULAR NEUROBIOLOGY, 1989, 3 (1-2) :71-100
[2]   Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD [J].
Ahmadian, G ;
Ju, W ;
Liu, LD ;
Wyszynski, M ;
Lee, SH ;
Dunah, AW ;
Taghibiglou, C ;
Wang, YS ;
Lu, J ;
Wong, TP ;
Sheng, M ;
Wang, YT .
EMBO JOURNAL, 2004, 23 (05) :1040-1050
[3]   Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial [J].
Aisen, PS ;
Schafer, KA ;
Grundman, M ;
Pfeiffer, E ;
Sano, M ;
Davis, KL ;
Farlow, MR ;
Jin, S ;
Thomas, RG ;
Thal, LJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2819-2826
[4]   A randomized controlled trial of prednisone in Alzheimer's disease [J].
Aisen, PS ;
Davis, KL ;
Berg, JD ;
Schafer, K ;
Campbell, K ;
Thomas, RG ;
Weiner, MF ;
Farlow, MR ;
Sano, M ;
Grundman, M ;
Thal, LJ .
NEUROLOGY, 2000, 54 (03) :588-593
[5]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[6]   The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease [J].
Aksenov, MY ;
Tucker, HM ;
Nair, P ;
Aksenova, MV ;
Butterfield, DA ;
Estus, S ;
Markesbery, WR .
NEUROCHEMICAL RESEARCH, 1999, 24 (06) :767-774
[7]  
Alzheimer A., 1907, Allg Zeitschrift Psychiatr, V64, P146, DOI DOI 10.1002/CA.980080612
[8]   Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells [J].
Anandatheerthavarada, HK ;
Biswas, G ;
Robin, MA ;
Avadhani, NG .
JOURNAL OF CELL BIOLOGY, 2003, 161 (01) :41-54
[9]   Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients [J].
Anello, M ;
Lupi, R ;
Spampinato, D ;
Piro, S ;
Masini, M ;
Boggi, U ;
Del Prato, S ;
Rabuazzo, AM ;
Purrello, F ;
Marchetti, P .
DIABETOLOGIA, 2005, 48 (02) :282-289
[10]   Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes [J].
Anguiano, M ;
Nowak, RJ ;
Lansbury, PT .
BIOCHEMISTRY, 2002, 41 (38) :11338-11343